Trials / Sponsors / Escient Pharmaceuticals, Inc
Escient Pharmaceuticals, Inc
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | An Open-Label Phase 1 Study in Healthy Male Subjects to Investigate the Absorption, Metabolism and Excretion o Healthy Participants | Phase 1 | 2024-10-01 |
| Completed | Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmac Atopic Dermatitis | Phase 2 | 2023-10-25 |
| Terminated | Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in S Chronic Spontaneous Urticaria | Phase 2 | 2023-09-25 |
| Completed | Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects Wit Chronic Inducible Urticaria | Phase 1 | 2023-08-30 |
| Completed | Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sc Pruritus | Phase 2 | 2022-10-06 |
| Completed | Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus, Cholestasis, Kidney Failure | Phase 1 | 2020-09-07 |